Today: 12 May 2026
Figure Technology Extends Post-Earnings Bid as Loan Volume Resets the Growth Debate
12 May 2026
3 mins read

Figure Technology Extends Post-Earnings Bid as Loan Volume Resets the Growth Debate

New York, May 12, 2026, 07:14 EDT

  • Figure Technology shares looked set to open higher following first-quarter numbers: record consumer loan marketplace volume, net revenue hitting $167 million, and Q2 volume guidance topping last quarter’s numbers.
  • This isn’t just about an EPS beat—scale and volume are the drivers now. Jefferies bumped its price target up to $43 from $37, sticking with Hold.
  • Here’s the upside: blockchain-based lending volumes keep expanding. On the flip side, valuation looks stretched, higher rates sting, and there’s plenty of housing-credit risk—especially with Fed-cut odds still slim, according to .

Figure Technology Solutions shares caught a premarket lift Tuesday after its Q1 numbers delivered what bulls have been looking for—ongoing loan growth, despite headwinds from rates. At 7:11 a.m. Eastern, MarketBeat quoted FIGR at $40.42 in after-hours action, marking a 3.73% rise from Monday’s close of $38.97.

The reason’s straightforward enough. Figure is projecting consumer loan marketplace volume for Q2 between $3.8 billion and $4.1 billion—up from $2.9 billion in Q1, and topping Jefferies’ previous expectation of $3.2 billion. For a marketplace lender, volume drives everything: more loans mean increased fees, a bigger data pool, and fresh incentives for both buyers and originators to stick around.

Q1 wasn’t just about beating the top line. Consumer Loan Marketplace volume shot up 113% year-on-year to $2.9 billion. Net revenue landed at $167 million, up 98%. Net income totaled $45 million, while adjusted EBITDA—profit before interest, taxes, depreciation, amortization, and certain company-specific tweaks—jumped 192% to $83 million.

Investors seemed to favor the source of the volume this quarter. Figure Connect, the firm’s loan marketplace, hit $1.6 billion—accounting for 56% of its consumer loan marketplace volume. At quarter’s end, the company tallied 387 active partners and brought on board a record 80 new ones. First-lien production, referring to mortgages with top claim on a property, now represents 20% of total production.

Management doubled down on that theme, with CEO Michael Tannenbaum calling the results proof of the “resilience of our capital-light model.” That’s a key point for Figure, which is out to show it doesn’t need to pile loans onto its own balance sheet to grow. This is the simpler narrative for the stock today. GlobeNewswire

Bulls are betting that Figure is stepping out of its home-equity corner and building something much bigger in capital markets. Net take rate? 3.8%—that’s what Figure actually pockets per dollar running through its consumer marketplace. Cash and equivalents stood at $1.5 billion at the end of the quarter. Should Q2 volume reach the upper end of the company’s forecast, Q1 probably won’t look like a one-off; investors may see it as a reset point.

No shortage of red flags on the bear side. Figure remains tied to HELOCs—loans that ride on the back of homeowners’ equity. Lenders face layers: property prices, borrower quality, warehouse lines, appetite from loan buyers, even regulatory angles around digital assets—all factor in. Shares moved between about $25 and $78 over the last 52 weeks, so “steady compounder” isn’t the story here. GlobeNewswire

Rates push the divide further. Data from prediction markets puts the odds of the Fed standing pat in June at 96.7%—with Polymarket pricing in 96.8%, and Kalshi just behind at 96.5%. Figure’s volume pickup stands out against that backdrop, though it’s no signal that lending or funding costs will get a boost from policy shifts any time soon.

Sell-side views have hardly settled. Jefferies bumped up its price target to $43 from $37, citing robust volumes, yet left its Hold rating unchanged. Their note flagged just how scattered analyst targets are, ranging anywhere from $31 to $75. In short: consensus on Figure’s rapid growth, but little agreement on the payoff.

Peer reactions are all over the map. SoFi hit new highs in lending and member additions, yet came up short for some after its outlook failed to budge. Affirm pushed strong volume numbers too, but investors still zeroed in on credit health and the risk of missed payments. Upstart, caught in the same digital-lending cross-currents, faces similar scrutiny. What sets Figure apart for now: it handed investors a look ahead at growing volumes, rather than just the last quarter’s stats.

Longer-term context is key here. Figure hit the public market in September, pricing shares at $25 and pulling in $787.5 million through its IPO—good for a $5.29 billion valuation. Back then, Figure told Reuters it could originate home-equity loans in just 10 days, far outpacing the 42-day average across the industry. That pitch—speed—remains a core plank of the story.

The focus now shifts to the 8:30 a.m. Eastern earnings call. Everyone’s going to want to know: Is Q2 guidance pretty much locked in? Will the take rate stay put with Figure Connect picking up steam? What does first-lien lending do to margins, and is credit still looking solid? Right now, this morning’s move reflects confidence the company can deliver. The call needs to back that up.

Stock Market Today

  • Wabash National (WNC) Slides Into Oversold Territory with RSI at 29.2
    May 12, 2026, 5:19 PM EDT. Shares of Wabash National Corp (WNC) fell to a 52-week low of $6.79, pushing its Relative Strength Index (RSI) to 29.2, signaling the stock as oversold according to technical analysis. The RSI, which measures momentum on a scale from 0 to 100, indicates a reading below 30 may suggest selling pressure is peaking. This contrasts with the S&P 500 ETF's high RSI of 78.7. Investors following Warren Buffett's advice might view WNC's current state as a potential buying opportunity amid market fears. WNC's 52-week high stands at $12.94, with the latest trade near the bottom of its range at $6.95.

Latest article

Ernexa Stock’s 58% Jump Shows How Fast a Tiny Biotech Can Reprice on Ovarian-Cancer Hopes

Ernexa Stock’s 58% Jump Shows How Fast a Tiny Biotech Can Reprice on Ovarian-Cancer Hopes

12 May 2026
Ernexa Therapeutics shares jumped 58.5% to $11.43 Tuesday after renewed investor focus on its preclinical ovarian-cancer therapy ERNA-101, following a May 11 investor event. Trading volume reached about 18.85 million shares. The company reported $8.3 million in cash as of April 30, less than needed for its 12-month plan, and may use an at-the-market stock sale to raise funds.
UnitedHealth Stock Climbs as Investors Reprice the Turnaround, Not Just the Latest Headline

UnitedHealth Stock Climbs as Investors Reprice the Turnaround, Not Just the Latest Headline

12 May 2026
UnitedHealth shares climbed 3.1% to $396.45 Tuesday after unveiling a new Optum Rx fee-based pricing model and raising 2026 profit guidance. The company reported Q1 revenue of $111.7 billion and adjusted earnings of $7.23 per share. Management said fundamentals are improving but described the turnaround as ongoing. Investors responded to both the PBM overhaul and stronger earnings outlook.
BuzzFeed Stock Nearly Doubles as Byron Allen Deal Buys Time, Not a Clean Turnaround

BuzzFeed Stock Nearly Doubles as Byron Allen Deal Buys Time, Not a Clean Turnaround

12 May 2026
BuzzFeed shares jumped 97% to about $1.44 Tuesday after Byron Allen’s family office agreed to buy 40 million new shares at $3 each, securing 52% control. Only $20 million is due in cash at closing, with the rest as a five-year promissory note. BuzzFeed reported Q1 revenue down 12.4% to $31.6 million and a net loss of $15.1 million. The company warned of “substantial doubt” about its ability to continue operating.
India Stock Market Today: Sensex Erases 600-Point Jump, Nifty Holds 24,000 as Banks Cushion Drag
Previous Story

Sensex Crash Today: The Oil Shock Behind India’s $115 Billion Stock Wipeout

Cisco Stock Near a Record High as AI Orders Set Up a Tough Earnings Test
Next Story

Cisco Stock Near a Record High as AI Orders Set Up a Tough Earnings Test

Go toTop